Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 88
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Retinal ganglion cell circuits and glial interactions in humans and mice

Retinal ganglion cell circuits and glial interactions i...

 64

A hominoid-specific signaling axis regulating the tempo of synaptic maturation

A hominoid-specific signaling axis regulating the tempo...

 90

Aneuploidy-induced proteostasis disruption impairs mitochondrial functions and mediates aggregation of mitochondrial precursor proteins through SQSTM1/p62

Aneuploidy-induced proteostasis disruption impairs mito...

 99